107 related articles for article (PubMed ID: 19783967)
1. In vivo anti-tumor activities of gelatin.
Inamura Y; Koide T; Kojima T; Nagata H; Ito N; Suzumura K; Hashimoto Y
Exp Oncol; 2009 Sep; 31(3):144-8. PubMed ID: 19783967
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of murine peritoneal macrophages induced by porcine skin gelatin.
Koide T; Kojima T; Inamura Y; Nagata H; Hashimoto Y; Sugita Y; Maeda H
Exp Oncol; 2008 Dec; 30(4):300-5. PubMed ID: 19112428
[TBL] [Abstract][Full Text] [Related]
3. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells.
Hyoudou K; Nishikawa M; Ikemura M; Kobayashi Y; Mendelsohn A; Miyazaki N; Tabata Y; Yamashita F; Hashida M
J Control Release; 2007 Sep; 122(2):151-8. PubMed ID: 17651858
[TBL] [Abstract][Full Text] [Related]
4. Effect of hemostatics used during operations for digestive organ on cancer cells present in the peritoneal cavity.
Kubota N; Kojima T; Naruse T
Cancer Biother Radiopharm; 2000 Feb; 15(1):47-52. PubMed ID: 10740652
[TBL] [Abstract][Full Text] [Related]
5. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
7. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
8. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS
J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541
[TBL] [Abstract][Full Text] [Related]
9. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
10. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
[TBL] [Abstract][Full Text] [Related]
11. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant alpha-interferon-gelatin conjugate on in vivo murine tumor cell growth.
Tabata Y; Uno K; Yamaoka T; Ikada Y; Muramatsu S
Cancer Res; 1991 Oct; 51(20):5532-8. PubMed ID: 1833052
[TBL] [Abstract][Full Text] [Related]
17. Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice.
Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
J Gene Med; 2008 Apr; 10(4):392-9. PubMed ID: 18181219
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production.
Sun GP; Wang H; Xu SP; Shen YX; Wu Q; Chen ZD; Wei W
Eur J Pharmacol; 2008 Apr; 584(2-3):246-52. PubMed ID: 18329639
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
[TBL] [Abstract][Full Text] [Related]
20. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
Beuth J; Schierholz JM; Ko HL; Braun JM
In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
